Skip to main content

Advertisement

Log in

Dental students’ knowledge of characteristics and management of oral complications of cancer therapy

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Objective

The aim of this study is to investigate the level of Turkish senior dental students’ knowledge regarding the orodental complications and their treatment methods of cancer patients.

Study design

A 15-item questionnaire which was obtained from National Institute of Dental and Craniofacial Research that contained information about the orodental complications of the cancer therapy and the dentists’ role to provide their treatment protocols was used. Seventy-seven senior dental students answered the questionnaire and the replies were analyzed with stratified and logistic data analyses.

Results

Overall, correct replies ranged from 5.2 to 98.7 %. The students knew the basic knowledge of the complications of cancer therapy; however, they failed to answer to the questions (ranging between 1.3 and 94.8 %) about the required clinical practices. The respondents preferred not to answer the questions about the prophylactic measures dentist shall take during a precancer treatment oral evaluation (9.1 %), management of pain in cancer treatment (6.5 %), and necessary considerations before a dental procedure in a chemotherapy patient (3.9 %). The multiple logistic regression analysis revealed that gender had no statistically significant effect on the correct or false answers to the questions (p > 0.05).

Conclusion

Our results disclosed that dental students’ knowledge about oral complications of cancer therapy and the modalities to manage these complications vary. Reevaluation of current undergraduate curricula and continuing education for graduates might address the gaps identified and an educational program about oral and dental management of patients who are to receive/receiving/have received cancer therapy can be prepared and augmented into dental curriculum.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Hong CH, Napeñas JJ, Hodgson BD, Stokman MA, Mathers-Stauffer V, Elting LS, Spijkervet FK, Brennan MT, Dental Disease Section, Oral Care Study Group, Multi-National Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO) (2010) A systematic review of dental disease in patients undergoing cancer therapy. Support Care Cancer 18:1007–1021

    Article  PubMed  Google Scholar 

  2. Barker GJ, Epstein JB, Williams KB, Gorsky M, Raber-Durlacher JE (2005) Current practice and knowledge of oral care for cancer patients: a survey of supportive health care providers. Support Care Cancer 13:32–41

    Article  PubMed  Google Scholar 

  3. Epstein JB, Parker IR, Epstein MS, Gupta A, Kutis S, Witkowski DM (2007) A survey of National Cancer Institute-designated comprehensive cancer centers’ oral health supportive care practices and resources in the USA. Support Care Cancer 15:357–362

    Article  PubMed  Google Scholar 

  4. Epstein JB, Thariat J, Bensadoun RJ, Barasch A, Murphy BA, Kolnick L, Popplewell L, Maghami E (2012) Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin 62:400–422

    Article  PubMed  Google Scholar 

  5. Roe JW, Carding PN, Rhys-Evans PH, Newbold KL, Harrington KJ, Nutting CM (2012) Assessment and management of dysphagia in patients with head and neck cancer who receive radiotherapy in the United Kingdom—a web-based survey. Oral Oncol 48:343–348

    Article  PubMed  Google Scholar 

  6. Brennan MT, Elting LS, Spijkervet FK (2010) Systematic reviews of oral complications from cancer therapies, Oral Care Study Group, MASCC/ISOO: methodology and quality of the literature. Support Care Cancer 18:979–984

    Article  PubMed  Google Scholar 

  7. Barasch A, Epstein JB (2011) Management of cancer therapy-induced oral mucositis. Dermatol Ther 24:424–431

    Article  PubMed  Google Scholar 

  8. Watters AL, Epstein JB, Agulnik M (2011) Oral complications of targeted cancer therapies: a narrative literature review. Oral Oncol 47:441–448

    Article  CAS  PubMed  Google Scholar 

  9. Cooperstein E, Gilbert J, Epstein JB, Dietrich MS, Bond SM, Ridner SH, Wells N, Cmelak A, Murphy BA (2012) Vanderbilt Head and Neck Symptom Survey version 2.0: report of the development and initial testing of a subscale for assessment of oral health. Head Neck 34:797–804

    Article  PubMed  Google Scholar 

  10. Andrews N, Griffiths C (2001) Dental complications of head and neck radiotherapy: part 1. Aust Dent J 46:88–94, Review

    Article  CAS  PubMed  Google Scholar 

  11. Mealey BL, Semba SE, Hallmon WW (1994) The head and neck radiotherapy patient: Part 2—Management of oral complications. Compendium 15:442, 444, 446–452 passim; quiz 458

    Google Scholar 

  12. Shieh SH, Wang ST, Tsai ST, Tseng CC (1997) Mouth care for nasopharyngeal cancer patients undergoing radiotherapy. Oral Oncol 33:36–41

    Article  CAS  PubMed  Google Scholar 

  13. Miller M, Kearney N (2001) Oral care for patients with cancer: a review of the literature. Cancer Nurs 24:241–254, Review

    Article  CAS  PubMed  Google Scholar 

  14. Rautemaa R, Lauhio A, Cullinan MP, Seymour GJ (2007) Oral infections and systemic disease—an emerging problem in medicine. Clin Microbiol Infect 13:1041–1047

    Article  CAS  PubMed  Google Scholar 

  15. Rogers SN (2009) Quality of life for head and neck cancer patients—has treatment planning altered? Oral Oncol 45:435–439

    Article  PubMed  Google Scholar 

  16. Rogers SN (2010) Quality of life perspectives in patients with oral cancer. Oral Oncol 46:445–447

    Article  PubMed  Google Scholar 

  17. Bensadoun RJ, Patton LL, Lalla RV, Epstein JB (2011) Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011. Support Care Cancer 19:737–744

    Article  PubMed  Google Scholar 

  18. Mosel DD, Bauer RL, Lynch DP, Hwang ST (2011) Oral complications in the treatment of cancer patients. Oral Dis 17:550–559

    Article  CAS  PubMed  Google Scholar 

  19. Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE, Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV, For The Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) (2013) Systematic review of amifostine for the management of oral mucositis in cancer patients. Support Care Cancer 21:357–364

    Article  PubMed  Google Scholar 

  20. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE, Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 1(109):820–831

    Article  Google Scholar 

  21. Scully C, Sonis S, Diz PD (2006) Oral mucositis. Oral Dis 12:229–241

    Article  CAS  PubMed  Google Scholar 

  22. Jacobson JJ, Epstein JB, Eichmiller FC, Gibson TB, Carls GS, Vogtmann E, Wang S, Murphy B (2012) The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, Medicare, and Medicaid. Head Neck Oncol 4:15

    Article  PubMed  Google Scholar 

  23. Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P (2001) Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 23:389–398

    Article  CAS  PubMed  Google Scholar 

  24. Jones DL, Rankin KV (2012) Management of the oral sequelae of cancer therapy. Tex Dent J 129:461–468

    PubMed  Google Scholar 

  25. Vijay Kumar KV, Suresan V (2012) Knowledge, attitude and screening practices of general dentists concerning oral cancer in Bangalore city. Indian J Cancer 49:33–38. doi:10.4103/0019-509X.98915

    Article  CAS  PubMed  Google Scholar 

  26. Monteiro LS, Salazar F, Pacheco J, Warnakulasuriya S (2012) Oral cancer awareness and knowledge in the city of Valongo, Portugal. Int J Dent 2012:376838. doi:10.1155/2012/376838. Epub 2012 7

    PubMed  Google Scholar 

  27. Güneri P, Cankaya H, Kaya A, Boyacioğlu H (2008) Turkish dentists’ knowledge of head and neck cancer therapy-related complications: implications for the future. Eur J Cancer Care 17:84–92

    Google Scholar 

  28. Raber-Durlacher JE, Epstein JB, Raber J, van Dissel JT, van Winkelhoff AJ, Guiot HF, van der Velden U (2002) Periodontal infection in cancer patients treated with high-dose chemotherapy. Support Care Cancer 10:466–473

    Article  PubMed  Google Scholar 

  29. Patel Y, Bahlhorn H, Zafar S, Zwetchkenbaum S, Eisbruch A, Murdoch-Kinch CA (2012) Survey of Michigan dentists and radiation oncologists on oral care of patients undergoing head and neck radiation therapy. J Mich Dent Assoc 94:34–45

    PubMed  Google Scholar 

  30. Mainali A, Sumanth KN, Ongole R, Denny C (2011) Dental consultation in patients planned for/undergoing/post radiation therapy for head and neck cancers: a questionnaire-based survey. Indian J Dent Res 22:669–672

    Article  PubMed  Google Scholar 

  31. Jaber MA, Diz Dios P, Vázquez García E, Cutando Soriano A, Porter SR (1997) Spanish dental students knowledge of oral malignancy and premalignancy. Eur J Dent Educ 1:167–171

    CAS  PubMed  Google Scholar 

  32. Uti OG, Fashina AA (2006) Oral cancer education in dental schools: knowledge and experience of Nigerian undergraduate students. J Dent Educ 70:676–680

    PubMed  Google Scholar 

  33. Boroumand S, Garcia AI, Selwitz RH, Goodman HS (2008) Knowledge and opinions regarding oral cancer among Maryland dental students. J Cancer Educ 23:85–91

    Article  PubMed  Google Scholar 

  34. Chowdhury MT, Pau A, Croucher R (2010) Bangladeshi dental students' knowledge, attitudes and behaviour regarding tobacco control and oral cancer. J Cancer Educ 25:391–395

    Article  PubMed  Google Scholar 

  35. Ogden GR, Mahboobi N (2011) Oral cancer awareness among undergraduate dental students in Iran. J Cancer Educ 26:380–385

    Article  PubMed  Google Scholar 

  36. LeHew CW, Epstein JB, Kaste LM, Choi YK (2010) Assessing oral cancer early detection: clarifying dentists' practices. J Public Health Dent 70:93–100

    PubMed  Google Scholar 

  37. Odell EW, Farthing PM, High A, Potts J, Soames J, Thakker N, Toner M, Williams HK (2004) British Society for Oral and Maxillofacial Pathology, UK: minimum curriculum in oral pathology. Eur J Dent Educ 8:177–184

    Article  CAS  PubMed  Google Scholar 

  38. Rich JP 3rd, Straffon L, Inglehart MR (2006) General dentists and pediatric dental patients: the role of dental education. J Dent Educ 70:1308–1315

    PubMed  Google Scholar 

  39. Cannick GF, Horowitz AM, Garr DR, Reed SG, Neville BW, Day TA, Woolson RF, Lackland DT (2007) Oral cancer prevention and early detection: using the PRECEDE-PROCEED framework to guide the training of health professional students. J Cancer Educ 22:250–253

    Article  PubMed  Google Scholar 

  40. Canto MT, Horowitz AM, Drury TF, Goodman HS (2002) Maryland family physicians’ knowledge, opinions and practices about oral cancer. Oral Oncol 38:416–424

    Article  PubMed  Google Scholar 

  41. Clovis JB, Horowitz AM, Poel DH (2002) Oral and pharyngeal cancer: knowledge and opinions of dentists in British Columbia and Nova Scotia. J Can Dent Assoc 68:415–420

    PubMed  Google Scholar 

  42. Hofmann BM, Eriksen HM (2001) The concept of disease: ethical challenges and relevance to dentistry and dental education. Eur J Dent Educ 5:2–8

    Article  CAS  PubMed  Google Scholar 

  43. Epstein JB, van der Meij EH, Emerton SM, Le ND, Stevenson-Moore P (1995) Compliance with fluoride gel use in irradiated patients. Spec Care Dentist 15(6):218–222

    Article  CAS  PubMed  Google Scholar 

  44. Hogan R (2009) Implementation of an oral care protocol and its effects on oral mucositis. J Pediatr Oncol Nurs 26:125–135

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Esin Alpöz.

Appendix 1

Appendix 1

Original questionnaire

  1. 1.

    Which of the following statements about the oral complications of chemotherapy and head and neck radiation is not correct?

    1. (a)

      Oral mucositis can increase the risk of oral pain and systemic infection.

    2. (b)

      Oral complications may lead to lowering the dosages and possibly discontinuing cancer treatment.

    3. (c)

      High dosages of chemotherapy or radiation therapy cannot affect dental, craniofacial, or skeletal development in children.

    4. (d)

      Patients undergoing cancer treatment may experience alterations in taste perception.

  2. 2.

    Dental decay occurs more rapidly after head and neck radiation treatment because

    1. (a)

      there is a change in the flow rate for saliva

    2. (b)

      there is a change in the composition of saliva

    3. (c)

      the ability to taste is impaired

    4. (d)

      a and b only

  3. 3.

    What population is most likely to experience oral complications from cancer therapy?

    1. (a)

      Patients with melanoma treated with chemotherapy.

    2. (b)

      Patients with oral and pharyngeal cancer treated with radiation.

    3. (c)

      Patients with breast cancer treated with chemotherapy.

    4. (d)

      Patients with prostate cancer treated with radiation.

  4. 4.

    When oral care is added to the pretreatment regimen, which of the following is true?

    1. (a)

      There is an increased risk of oral complications.

    2. (b)

      The patient will have no oral complications from cancer therapy.

    3. (c)

      Pre-existing oral health problems will get worse.

    4. (d)

      It is more likely that the patient will be able to complete his or her optimal cancer treatment regimen.

  5. 5.

    What specific health information should an oral health professional have as part of the oral evaluation of a patient with cancer?

    1. (a)

      Cancer diagnosis and treatment plan

    2. (b)

      Medical history

    3. (c)

      Dental and periodontal oral examination data

    4. (d)

      All of the above

  6. 6.

    Which of the following oral complications may occur during and/or after head and neck radiation and chemotherapy?

    1. (a)

      Dry, friable oral tissues

    2. (b)

      Abnormal dental, craniofacial, or skeletal development

    3. (c)

      Oral mucositis

    4. (d)

      All of the above

  7. 7.

    Select the statements that apply (more than one answer may be correct): at a precancer treatment oral evaluation, the dentist will

    1. (a)

      Instruct the patient about the importance of proper oral hygiene during cancer treatment

    2. (b)

      Request that the patient stop wearing dentures during cancer treatment, even if there are no problems with fit or comfort

    3. (c)

      Examine hard and soft tissues and expose radiographs to detect oral conditions that may become problematic during cancer treatment

    4. (d)

      Remove all teeth that may present a problem in the future for patients undergoing head and neck radiation

  8. 8.

    For a patient experiencing xerostomia, recommend all of the following except

    1. (a)

      Sipping water

    2. (b)

      Chewing sugarless gum

    3. (c)

      Eating spicy foods to stimulate the salivary glands

    4. (d)

      Using liquid to soften foods

  9. 9.

    What can help a patient who is experiencing mouth pain?

    1. (a)

      Mouth rinse containing alcohol

    2. (b)

      Lip balm

    3. (c)

      Topical anesthetics

    4. (d)

      Chewing ice

  10. 10.

    Which of the following statements is true?

    1. (a)

      In general, high-dose radiation to the head and neck will not permanently alter salivary functioning.

    2. (b)

      Patients are at risk for osteonecrosis after receiving high-dose radiation treatment to the mandible.

    3. (c)

      Patients who have received high dose radiation to the mandible can safely undergo invasive surgery at this site 5 years after radiation therapy.

    4. (d)

      Patients who have received radiation to the head and neck are not at greater risk for caries than other patients receiving radiation treatment for cancer.

  11. 11.

    When should daily oral hygiene be suspended?

    1. (a)

      When the patient experiences mouth pain

    2. (b)

      When the patient has difficulty swallowing

    3. (c)

      When the patient has an oral infection

    4. (d)

      Never

  12. 12.

    Oral hazards of cancer treatment specific to children are

    1. (a)

      Osteonecrosis

    2. (b)

      Abnormal growth and development of the teeth and cranial bones

    3. (c)

      Complications from highly mobile primary teeth

    4. (d)

      Dental caries

    5. (e)

      b and c

  13. 13.

    Which of the following is not necessary before a dental procedure in a chemotherapy patient?

    1. (a)

      Completing all blood work, including platelet count, clotting factors and absolute neutrophil count 24 h before dental treatment

    2. (b)

      Prescribing 7 days of fluoride gel treatment

    3. (c)

      Scheduling myelosuppressive therapy more than 7–10 days after dental treatment

    4. (d)

      Considering a prophylactic antibiotic regimen for patients with a central venous catheter

  14. 14.

    The timing of dental procedures in relation to cancer treatment is very important. Which of the following is incorrect?

    1. (a)

      Dental evaluation: schedule it every 4–8 weeks for the first 6 months after radiation.

    2. (b)

      Oral surgery: allow 7–10 days of healing before the patient receives myelosuppressive chemotherapy.

    3. (c)

      Blood work: perform 24 h before dental treatment for chemotherapy patients.

    4. (d)

      Post-stem cell transplantation dental recalls, including dental scaling: perform regularly for the first 3 months after treatment.

  15. 15.

    The oral cavity is often subject to complications from cancer treatment because

    1. (a)

      All foods aggravate weakened tissues

    2. (b)

      Many patients experience hypersalivation

    3. (c)

      Tissue in the oral cavity thickens

    4. (d)

      Soft tissues in the mouth become easily desiccated, damaged, and infected

Correct answers: 1, c; 2, d; 3, b; 4, d; 5, d; 6, d; 7, a–d; 8, c; 9, d; 10, b; 11, d; 12, e; 13, c; 14, a; 15, d

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alpöz, E., Güneri, P., Epstein, J.B. et al. Dental students’ knowledge of characteristics and management of oral complications of cancer therapy. Support Care Cancer 21, 2793–2798 (2013). https://doi.org/10.1007/s00520-013-1856-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-013-1856-x

Keywords

Navigation